The first Pharmacovigilance conference in Israel
will be held on February 10, 2013 in Herzeliya. The Israeli Ministry of Health has adopted recently the European pharmacovigilance guideline for side effects and safety data reporting. The conference will address this guideline and the how the relevant stake holders are getting ready towards adopting it. (Hebrew)
The Food and Drug Administration (FDA) is announcing the availability of a guidance for the industry and FDA staff entitled "Humanitarian Use Device (HUD) Designations."
This guidance document is intended to assist applicants in the preparation and submission of HUD designation requests and FDA reviewers in evaluating such requests.
The Food and Drug Administration (FDA) is announcing the availability of a Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide.
This guidance is intended to help small businesses understand and comply with FDA’s safety reporting regulations for human drug and biological products that are being investigated under an investigational new drug application (IND) and for drugs that are the subjects of bioavailability (BA) and bioequivalence (BE) studies that are exempt from the IND requirements.
Israeli Scientist Awarded Prestigious Physics Prize. Dr. Zohar Komargodski of the Weizmann Institute of Science was awarded the New Horizons in Physics prize in December.
The $100,000 annual prize is awarded by the Fundamental Physics Prize Foundation to three promising young researchers worldwide.
Google launches Tel Aviv start-up incubator.
A year after Google Inc. (Nasdaq: GOOG) announced its plan to establish a start-up incubator and R&D center in Israel, the company today inaugurated the incubator in the presence of Prime Minister Benjamin Netanyahu.
Philips Healthcare sets up new R&D center in Haifa.
The center will focus on image processing and analysis, and conduct long-term research in the field as well develop applications for contemporary markets, such as virtual colonoscopy and virtual catheterization applications. President Shimon Peres: What I saw during my tour at Philips is greater than any of my dreams. You are developing the world's state-of-the-art medical instruments in Israel.